LON:AZNAstraZeneca Share Price, Forecast & News

GBX 8,626

+297.00 (+3.57 %)

(As of 05/28/2020 08:53 AM ET)

Add

Compare

Today's Range

8,483

Now: GBX 8,626▼

8,686.78

50-Day Range

6,971

MA: GBX 8,223.68▼

8,996

52-Week Range

5,739

Now: GBX 8,626▼

9,335

Volume839,832 shs

Average Volume2.31 million shs

Market Capitalization£113.19 billion

P/E Ratio74.55

Dividend Yield2.44%

BetaN/A

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
AstraZeneca has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 14 buy ratings, 2 hold ratings, and 4 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 8,168.89, AstraZeneca has a potential downside of 5.3% from its current price of GBX 8,626.
Amount of Analyst Coverage
AstraZeneca has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.4 Community Rank

Outperform Votes
AstraZeneca has received 1,578 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AstraZeneca has received 1,750 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AstraZeneca has received 52.58% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. Vote “Outperform” if you believe AZN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AZN will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
AstraZeneca is a leading dividend payer. It pays a dividend yield of 2.44%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
AstraZeneca does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of AstraZeneca is 188.42 %. Payout ratios above 75% are not desirable because they may not be sustainable.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AstraZeneca insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Earnings Growth
Earnings for AstraZeneca are expected to decrease by -100.00% in the coming year, from GBX 382 to GBX 0 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of AstraZeneca is 74.55, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.86.
Price to Earnings Ratio vs. Sector
The P/E ratio of AstraZeneca is 74.55, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.08.
Price to Book Value per Share Ratio
AstraZeneca has a P/B Ratio of 10.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.26 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON

Industry Drug Manufacturers - Major

Sub-IndustryN/A

SectorMedical

Current SymbolLON:AZN

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.astrazeneca.com

Phone+44-20-73045000

Debt

Debt-to-Equity Ratio171.72

Current Ratio0.75

Quick Ratio0.56

Price-To-Earnings

Trailing P/E Ratio74.55

Forward P/E Ratio22.58

P/E GrowthN/A

Sales & Book Value

Annual Sales£25.25 billion

Price / Sales4.48

Cash FlowGBX 304.44 per share

Price / Cash Flow28.33

Book ValueGBX 821.50 per share

Price / Book10.50

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees64,400

Outstanding Shares1,312,240,000

Market Cap£113.19 billion

Next Earnings Date7/30/2020 (Estimated)

OptionableOptionable

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

AstraZeneca (LON:AZN) Frequently Asked Questions

How has AstraZeneca's stock been impacted by COVID-19 (Coronavirus)?

AstraZeneca's stock was trading at GBX 6,955 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AZN shares have increased by 24.0% and is now trading at GBX 8,626. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AstraZeneca?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 4 sell ratings, 2 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AstraZeneca.

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for AstraZeneca.

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

AstraZeneca declared a dividend on Friday, February 14th. Shareholders of record on Thursday, February 27th will be paid a dividend of GBX 146.40 per share on Monday, March 30th. This represents a dividend yield of 1.92%. The ex-dividend date is Thursday, February 27th. This is a boost from AstraZeneca's previous dividend of GBX 71.90. The official announcement can be viewed at this link. View AstraZeneca's dividend history.

What price target have analysts set for AZN?

20 Wall Street analysts have issued 12-month price targets for AstraZeneca's stock. Their forecasts range from GBX 6,000 to £100. On average, they expect AstraZeneca's stock price to reach GBX 8,168.89 in the next year. This suggests that the stock has a possible downside of 5.3%. View analysts' price targets for AstraZeneca.

Has AstraZeneca been receiving favorable news coverage?

Media headlines about AZN stock have been trending somewhat negative on Thursday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. AstraZeneca earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutAstraZeneca.

Who are some of AstraZeneca's key competitors?

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer (BAYN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Opthea (OPT), Mayne Pharma Group (MYX), Vectura Group (VEC), Medical Developments International (MVP), BEXIMCO PHARMAC/S GDR REGS (BXP), Eco Animal Health Group (EAH), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), Recce Pharmaceuticals (RCE), Futura Medical (FUM) and NanoViricides (NNVC). View all competitors.

What other stocks do shareholders of AstraZeneca own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Vodafone Group (VOD), Hain Celestial Group (HAIN), NVIDIA (NVDA), Gilead Sciences (GILD), Royal Dutch Shell (RDSB), Intel (INTC), National Retail Properties (NNN), BP (BP) and Johnson & Johnson (JNJ).

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the following people:

Mr. Pascal Soriot, CEO & Exec. Director (Age 60)
Mr. Marc Dunoyer, CFO & Exec. Director (Age 67)
Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 48)
Thomas Kudsk Larsen, Head of Investor Relations
Mr. Jefrey Pott, Gen. Counsel

What is AstraZeneca's stock symbol?

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How do I buy shares of AstraZeneca?

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately GBX 8,626.

How big of a company is AstraZeneca?

AstraZeneca has a market capitalization of £113.19 billion and generates £25.25 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.

What is AstraZeneca's official website?

The official website for AstraZeneca is www.astrazeneca.com.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.

This page was last updated on 5/28/2020 by MarketBeat.com Staff